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1. Introduction 
Lucensomycin is a macrolide polyenic antibiotic 
formed by a mycosamine moiety linked by a glyco- 
sidic bond to a Czs lactone ring which contains a 
tetraene sequence [l] . Like other related polyenes, 
it is known to affect the permeability of cholesterol- 
containing biological or artificial membranes [2-51. 
It has recently been shown that addition of this com- 
pound to tumour cells in vitro results in a severe in- 
hibition of nucleic acid biosynthesis [6,7]. This 
effect is strictly correlated to the alterations of the 
plasma membrane of the cells [7]. 
We report here a spectrofluorimetric investiga- 
tion of the binding of lucensomycin to erythrocyte 
ghosts. 
2. Methods 
Erythrocyte ghosts were prepared according to 
Dodge et al. [8], with minor modifications, and re- 
suspended in isotonic NaCl t isotonic phosphate 
buffer pH 6.8 (9: 1, v/v). Lucensomycin and N-ace- 
tyl-lucensomycin were a kind gift of Prof. F. Arca- 
mone and Prof. M. Ghione of Farmitalia, Milano, 
Italy. They were kept as dry powders under nitro- 
gen at t4’ until use, then dissolved at 5 mg/ml in 
dimethylsulfoxide, and this stock solution diluted 
in the appropriate solvent. 
The fluorescence spectra were recorded in an 
Aminco-Bowman spectrophotofluorometer using 
1 cm cuvettes, excitation slit of 0.1 mm and emission 
slit between 0.1 and 0.5 mm. Temperature was con- 
stantly kept at 24”. All spectra were recorded 2 to 
3 hr after preparation of the sample, so as to allow 
complete equilibration. 
Absorption spectra were recorded in a Beckman 
DB spectrophotometer. 
Proteins were determined according to Gomall 
et al. [9] and verified by use of a Coleman Nitrogen 
Analyser. Cholesterol was determined with the 
15949 TCAA Calorimetric test of Boehringer, Mann- 
heim, Germany. 
In all experiments reported, the same membrane 
preparation, containing 1.3 mg protein/ml and 1.9 
mg cholesterol/ml was used. Other preparations, 
anyhow, were found to behave in an identical manner. 
3. Results 
Fig. 1 shows the fluorescence characteristics of 
lucensomycin in saline-phosphate buffer, in the ab- 
sence or in the presence of erythrocyte ghosts, and 
in a dioxane-water mixture (11: 1, v/v). It may be 
noted that the fluorescence intensity, which was 
extremely low in aqueous medium, increased con- 
siderably upon addition of membranes. The excita- 
tion and emission spectra, apart from the differences 
in intensity, had very similar shapes in the three 
cases, except for a 20 nm blue shift of the low inten- 
sity emission maxima of lucensomycin alone in 
saline-phosphate buffer. No clearcut difference in 
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Fig. 1. Excitation and emission fluorescence spectra of lucensomycin. The spectra were recorded with excitation and emission 
slits of 0.1 mm. Fluorescence is expressed as conventional units (1 unit = 1.6 MV) Lucensomycin concentration: 3 rg/ml in 
dioxane (curve D); in saline-phosphate buffer (curve B), or in saline-phosphate buffer containing, per ml, 50~1 of erythrocyte 
membrane preparation (curve M). The curves were uncorrected for background fluorescence, for scattering or for different ab- 
sorption. 
Fig. 2. Dependence of fluorescence intensity upon addition of membranes. Excitation at 308 nm, slit 0.1 mm; emission at 410 nm, 
slit 0.5 mm. Curve A (0): 9 fig lucensomycin/ml; Curve B (0): 0.45 pg lucensomycin/ml, in saline-phosphate buffer. Fluorescence 
intensity, expressed as conventional units (1 unit = 1.6 PV), was brought to comparable values by referring to the amount of lu- 
censomycin per ml. The low fluorescence of lucensomycin in buffer without membranes was substracted from all the data. 
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Fig. 3. Dependence of fluorescence intensity upon dilution of lucensomycin-membrane mixtures. Conditions as in fig. 2. Fluor- 
escence expressed in conventional units as indicated in frgs. 1 and 2. Curve A ( A---+: 11.1~1 membranes/fig lucensomycin; 
Curve B (o-o): 0.22 ~1 membranes/Mg lucensomycin. 
the absorption spectra, either in shape or in intensity 
could be evidenced. 
Fig. 2 shows how the increase of fluorescence 
emission depends upon the amount of membrane 
added. The quantum yield, at infinite membrane 
concentration from the area of the emission curve 
by use of a quinine disulfate standard [lo], was 
about 0.25, while in the absence of membranes it 
wasaslowas0.3X 10e3. 
Although formaldehyde treatment according to 
Butler [ 1 l] makes erythrocytes resistant to lucenso- 
mycin-induced lysis [ 121, formaldehyde-treated 
erythrocyte membranes were still able to cause the 
increase of lucensomycin fluorescence. Other treat- 
ment, such as sonication (3 X 5 set in a MSE 100 W 
sonifier), or exposure to 70’ for 30 min, or shaking 
with 3 volumes of chloroform-methanol 3: 1 (with- 
out separation of the phases, but followed by eva- 
poration and resuspension by sonication in water), 
were also unable to modify the capacity of the mem- 
branes to enhance lucensomycin fluorescence. 
Table 1 
Solvent Dielectric 
constant 
Ip 
n-Hexane 1.9 0.024 
Dioxane 2.2 0.413 
Chloroform 4.8 0.118 
ZChloroethanol 25 0.085 
Ethylene glycol 37 0.080 
Dimethylsulfoxide 45 0.173 
Water 80 0.010 
Formamide 109 0.054 
Membranes, 50 pi/ml in 
water - 3.59 
Effects of different solvents on fluorescence of lucensomycin 
solutions.Lucensomycin was 3 pg/ml. Fluorescence intensity 
was measured with identical settings of the spectrophoto- 
fluorometer, with excitation at 308 nm and emission at 410 
mn. All values were corrected for background fluorescence of 
solvent. For comparison, the fluorescence of lucensomycin af. 
ter addition of a quasi-saturating amount of membranes is re- 
ported. 
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Fig. 4. Fluorescence of lucenosmycin in dioxane-water mix- 
tures. Lucensomycin concentration: 3 pg/ml. Other condi- 
tions as in fig. 2. -: fluorescence of dioxane-water mix- 
tures; l : fluorescence after addition of 50 ~1 membranes/ml. 
Fig. 3 shows the variation of fluorescence inten- 
sity upon dilution of lucensomycin-membrane mix- 
tures. Apart from the expected quenching at high lu- 
censomycin and/or membrane concentrations, due 
to self-absorption and, even more, to light scattering, 
it was found that dilution caused fluorescence to 
decrease more than would be expected by simple 
proportionality. This phenomenon may possibly be 
attributed to a dissociation of the fluorescent lucen- 
somycin-membrane complex. 
The high quantum yield of membrane-bound 
lucensomycin is not due to its location in a hydro- 
phobic environment, as shown by experiments in 
which the polyene was dissolved in solvents of dif- 
ferent dielectric constants (table 1): fluorescence 
Fig. 5. Plot of [M] tot/q vs l/(qas-9) (see text). Different 
symbols indicate different experiments with varying lucenso- 
mycin and/or membrane concentrations. [M] tot is expressed 
as ~1 membranes/ml of solution; 9 and 9as in conventional 
units (same as in figs. 1 and 2). Other experimental condi- 
tions as indicated in fig. 2. 
intensity was stronger in dimethylsulfoxide or 
even in formamide than in n-hexane, and reached 
its highest values in dioxane, where the quantum 
yield was found to be 0.026. Addition of increas- 
ing amount of water to lucensomycin in dioxane 
caused a progressive decrease of fluorescence 
(fig. 4). Addition of erythrocyte membranes to 
lucensomycin in dioxane did not cause an increase 
of fluorescence, unless the percentage of water in 
the solution was above 70%. 
N-Acetyllucensomycin, which is a slightly aci- 
dic derivative of lucensomycin obtained by acetyl- 
ation of the mycosamine moiety, had fluorescence 
properties in organic solvents similar to those of 
the parent compound, but did not become fluor- 
escent in aqueous solution upon addition of mem- 
branes. This behaviour is probably related to the 
lack of effectiveness of the N-acetyl derivative in 
increasing membrane permeability or in causing lysis 
of beef erythrocytes [5, 121. 
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4. Discussion 
Fluorescence appears to be an extremely sensitive 
method for evaluating the binding of lucensomycin 
to erythrocyte membranes, the quantum yield in- 
creasing more than SOO-fold. 
The results shown in fig. 2, together with the non- 
dependence of fluorescence intensity on the polarity 
of the solvent, suggest a simple reaction of the type 
L+M, .LM 
the fluorescence intensity t+~ being (apart from quench- 
ing effects due to high optical density or to high light 
scattering) proportional to the concentration of the 
LM complex, and reaching, at infinite membrane con- 
centration, an asymptotical value pas which depends 
only on total lucensomycin concentration. Mathema- 
tical analysis of this type of reaction predicts that a 
plot of [M] tot/p vs. l/(cp, - cp) would yield a straight 
line, the slope of which is the association constant, 
K,,, of the LM complex. Fig. 5 shows such a plot 
for data obtained form several experiments. 
The high fluorescence intensity of lucensomycin 
after addition of membranes is not correlated with 
a localization of the polyene in a hydrophobic en- 
vironment, as has been suggested for fluorescence 
charges of vitamin A [ 131, of 8-anilino-1-naphthalene 
sulfonate [ 14- 16 ] and of other fluorescent probes 
[ 171. In fact, not only is the fluorescence intensity 
oflucensomycin in organic solvents rather indepen- 
dent of the dielectric constant of the solvent, but 
even in dioxane, where fluorescence is hightest, the 
quantum yield reaches 10.4% of the value obtained 
with saturating amount of erythrocyte membranes. 
The ability to enhance lucensomycin fluorescence 
is modified neither by denaturation of membrane 
proteins by high temperatures, by formalinization or 
by organic solvents, nor by alteration of the phos- 
pholipid-protein association by sonication [ 181 or 
by chloroform-methanol treatment [ 191. Lucenso- 
mycin can therefore be used as a fluorescent probe 
only to detect gross changes in membrane architecture 
and/or composition. On the other hand, the use of 
polyenic antibiotics as probes for fine membrane struc- 
ture was a priori doubtful because of the conspicuous 
modifications of permeability they induce in mem- 
branes. 
The use of lucensomycin can be expected to allow 
the comparison of different membranes on the basis 
of two, and probably three, distinct parameters: the 
extent of fluorescence enhancement (i.e. the maxi- 
mum quantum yield which can be obtained at satu- 
rating membrane concentrations), the association con- 
stant between lucensomycin and membranes (as 
evaluated from experiments and plots analogous to 
those of figs. 3 and 5) and possibly the ability of 
membranes to bind lucensomycin also in the pres- 
ence of various amount of dioxane or of other suit- 
able organic solvents. 
A comparison between different membranes ap- 
pears of great interest in order to ascertain the struc- 
tural background of fluorescence enhancement, and 
to verify whether physicochemical measurements 
confirm the observation [ 161 of a different suscepti- 
bility to this antibiotic of membranes from “normal” 
and neoplastic cells. 
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